nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—FSHR—polycystic ovary syndrome	0.737	1	CbGaD
Suramin—FSHR—follicular fluid—polycystic ovary syndrome	0.0479	0.383	CbGeAlD
Suramin—FSHR—ovarian follicle—polycystic ovary syndrome	0.0216	0.173	CbGeAlD
Suramin—F2—urine—polycystic ovary syndrome	0.0026	0.0208	CbGeAlD
Suramin—FSHR—pituitary gland—polycystic ovary syndrome	0.00193	0.0155	CbGeAlD
Suramin—FSHR—adipose tissue—polycystic ovary syndrome	0.00192	0.0154	CbGeAlD
Suramin—FSHR—female gonad—polycystic ovary syndrome	0.00161	0.0129	CbGeAlD
Suramin—P2RY2—endocrine gland—polycystic ovary syndrome	0.00159	0.0127	CbGeAlD
Suramin—FSHR—endocrine gland—polycystic ovary syndrome	0.0015	0.012	CbGeAlD
Suramin—SIRT5—endometrium—polycystic ovary syndrome	0.0014	0.0112	CbGeAlD
Suramin—P2RX4—endometrium—polycystic ovary syndrome	0.00133	0.0106	CbGeAlD
Suramin—SIRT1—adrenal cortex—polycystic ovary syndrome	0.0013	0.0104	CbGeAlD
Suramin—SIRT5—pituitary gland—polycystic ovary syndrome	0.00127	0.0102	CbGeAlD
Suramin—SIRT5—adipose tissue—polycystic ovary syndrome	0.00126	0.0101	CbGeAlD
Suramin—P2RX4—pituitary gland—polycystic ovary syndrome	0.0012	0.00961	CbGeAlD
Suramin—P2RX4—adipose tissue—polycystic ovary syndrome	0.0012	0.00957	CbGeAlD
Suramin—SIRT1—endometrium—polycystic ovary syndrome	0.00116	0.0093	CbGeAlD
Suramin—SIRT5—adrenal gland—polycystic ovary syndrome	0.00113	0.00908	CbGeAlD
Suramin—P2RX4—adrenal gland—polycystic ovary syndrome	0.00107	0.00858	CbGeAlD
Suramin—SIRT1—uterus—polycystic ovary syndrome	0.00107	0.00857	CbGeAlD
Suramin—SIRT5—female gonad—polycystic ovary syndrome	0.00106	0.00846	CbGeAlD
Suramin—SIRT1—pituitary gland—polycystic ovary syndrome	0.00105	0.00842	CbGeAlD
Suramin—SIRT5—vagina—polycystic ovary syndrome	0.00105	0.00841	CbGeAlD
Suramin—SIRT1—adipose tissue—polycystic ovary syndrome	0.00105	0.00839	CbGeAlD
Suramin—ARSA—pituitary gland—polycystic ovary syndrome	0.00104	0.00832	CbGeAlD
Suramin—ARSA—adipose tissue—polycystic ovary syndrome	0.00104	0.00828	CbGeAlD
Suramin—P2RX4—female gonad—polycystic ovary syndrome	0.001	0.008	CbGeAlD
Suramin—P2RX4—vagina—polycystic ovary syndrome	0.000994	0.00796	CbGeAlD
Suramin—RYR1—uterus—polycystic ovary syndrome	0.00099	0.00792	CbGeAlD
Suramin—SIRT5—endocrine gland—polycystic ovary syndrome	0.000984	0.00787	CbGeAlD
Suramin—SIRT1—adrenal gland—polycystic ovary syndrome	0.00094	0.00752	CbGeAlD
Suramin—P2RX4—endocrine gland—polycystic ovary syndrome	0.00093	0.00744	CbGeAlD
Suramin—ARSA—adrenal gland—polycystic ovary syndrome	0.000929	0.00743	CbGeAlD
Suramin—PLA2G2A—adrenal cortex—polycystic ovary syndrome	0.000912	0.0073	CbGeAlD
Suramin—SIRT1—female gonad—polycystic ovary syndrome	0.000877	0.00701	CbGeAlD
Suramin—SIRT1—vagina—polycystic ovary syndrome	0.000871	0.00697	CbGeAlD
Suramin—RYR1—adrenal gland—polycystic ovary syndrome	0.000869	0.00695	CbGeAlD
Suramin—ARSA—female gonad—polycystic ovary syndrome	0.000866	0.00693	CbGeAlD
Suramin—ARSA—vagina—polycystic ovary syndrome	0.000861	0.00689	CbGeAlD
Suramin—SIRT1—endocrine gland—polycystic ovary syndrome	0.000815	0.00652	CbGeAlD
Suramin—PLA2G2A—endometrium—polycystic ovary syndrome	0.000814	0.00652	CbGeAlD
Suramin—ARSA—endocrine gland—polycystic ovary syndrome	0.000805	0.00644	CbGeAlD
Suramin—RYR1—vagina—polycystic ovary syndrome	0.000805	0.00644	CbGeAlD
Suramin—RYR1—endocrine gland—polycystic ovary syndrome	0.000753	0.00603	CbGeAlD
Suramin—PLA2G2A—pituitary gland—polycystic ovary syndrome	0.000737	0.0059	CbGeAlD
Suramin—PLA2G2A—adipose tissue—polycystic ovary syndrome	0.000734	0.00587	CbGeAlD
Suramin—PLA2G2A—adrenal gland—polycystic ovary syndrome	0.000658	0.00527	CbGeAlD
Suramin—PLA2G4A—adrenal cortex—polycystic ovary syndrome	0.000634	0.00507	CbGeAlD
Suramin—PLA2G2A—female gonad—polycystic ovary syndrome	0.000614	0.00491	CbGeAlD
Suramin—PLA2G2A—endocrine gland—polycystic ovary syndrome	0.000571	0.00457	CbGeAlD
Suramin—PLA2G4A—endometrium—polycystic ovary syndrome	0.000566	0.00453	CbGeAlD
Suramin—PLA2G4A—pituitary gland—polycystic ovary syndrome	0.000512	0.0041	CbGeAlD
Suramin—PLA2G4A—adipose tissue—polycystic ovary syndrome	0.00051	0.00408	CbGeAlD
Suramin—F2—adrenal gland—polycystic ovary syndrome	0.000497	0.00398	CbGeAlD
Suramin—F2—female gonad—polycystic ovary syndrome	0.000463	0.00371	CbGeAlD
Suramin—PLA2G4A—adrenal gland—polycystic ovary syndrome	0.000458	0.00366	CbGeAlD
Suramin—F2—endocrine gland—polycystic ovary syndrome	0.000431	0.00345	CbGeAlD
Suramin—PLA2G4A—female gonad—polycystic ovary syndrome	0.000427	0.00341	CbGeAlD
Suramin—PLA2G4A—vagina—polycystic ovary syndrome	0.000424	0.00339	CbGeAlD
Suramin—PLA2G4A—endocrine gland—polycystic ovary syndrome	0.000397	0.00318	CbGeAlD
Suramin—FSHR—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.95e-05	0.000213	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—LHB—polycystic ovary syndrome	2.93e-05	0.000212	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AKR1C2—polycystic ovary syndrome	2.93e-05	0.000212	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TEAD2—polycystic ovary syndrome	2.93e-05	0.000212	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—NR3C1—polycystic ovary syndrome	2.92e-05	0.000211	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.91e-05	0.00021	CbGpPWpGaD
Suramin—ARSA—Metabolism—GNAS—polycystic ovary syndrome	2.87e-05	0.000208	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	2.87e-05	0.000207	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—NAMPT—polycystic ovary syndrome	2.86e-05	0.000206	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.84e-05	0.000205	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	2.84e-05	0.000205	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP11A1—polycystic ovary syndrome	2.82e-05	0.000204	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	2.82e-05	0.000204	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	2.81e-05	0.000203	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PLAT—polycystic ovary syndrome	2.8e-05	0.000203	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	2.8e-05	0.000202	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—FSHR—polycystic ovary syndrome	2.8e-05	0.000202	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.8e-05	0.000202	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.79e-05	0.000202	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	2.79e-05	0.000202	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.77e-05	0.0002	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—SCT—polycystic ovary syndrome	2.75e-05	0.000199	CbGpPWpGaD
Suramin—ARSA—Metabolism—NCOR1—polycystic ovary syndrome	2.74e-05	0.000198	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NPB—polycystic ovary syndrome	2.71e-05	0.000196	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—LMNA—polycystic ovary syndrome	2.71e-05	0.000196	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	2.7e-05	0.000195	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	2.7e-05	0.000195	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	2.7e-05	0.000195	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GNAS—polycystic ovary syndrome	2.7e-05	0.000195	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	2.68e-05	0.000194	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—LHB—polycystic ovary syndrome	2.67e-05	0.000193	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—AKR1C3—polycystic ovary syndrome	2.66e-05	0.000192	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.66e-05	0.000192	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.65e-05	0.000192	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—GNAS—polycystic ovary syndrome	2.63e-05	0.00019	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	2.62e-05	0.00019	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP17A1—polycystic ovary syndrome	2.62e-05	0.000189	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.61e-05	0.000189	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	2.6e-05	0.000188	CbGpPWpGaD
Suramin—ARSA—Metabolism—CYP1A1—polycystic ovary syndrome	2.6e-05	0.000188	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.57e-05	0.000186	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	2.57e-05	0.000186	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	2.56e-05	0.000185	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NRG1—polycystic ovary syndrome	2.52e-05	0.000182	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—SCT—polycystic ovary syndrome	2.5e-05	0.00018	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTGER3—polycystic ovary syndrome	2.47e-05	0.000179	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LHCGR—polycystic ovary syndrome	2.47e-05	0.000179	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	2.47e-05	0.000178	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PNPLA2—polycystic ovary syndrome	2.46e-05	0.000177	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	2.45e-05	0.000177	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—LHB—polycystic ovary syndrome	2.44e-05	0.000176	CbGpPWpGaD
Suramin—ARSA—Metabolism—MTHFR—polycystic ovary syndrome	2.42e-05	0.000175	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—GHRL—polycystic ovary syndrome	2.41e-05	0.000174	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	2.38e-05	0.000172	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	2.38e-05	0.000172	CbGpPWpGaD
Suramin—F2—Hemostasis—GNAS—polycystic ovary syndrome	2.35e-05	0.00017	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—ACE—polycystic ovary syndrome	2.34e-05	0.000169	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SRD5A1—polycystic ovary syndrome	2.33e-05	0.000168	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	2.33e-05	0.000168	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTAFR—polycystic ovary syndrome	2.31e-05	0.000167	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—SCT—polycystic ovary syndrome	2.28e-05	0.000165	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TH—polycystic ovary syndrome	2.27e-05	0.000164	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—PPARG—polycystic ovary syndrome	2.26e-05	0.000164	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LHCGR—polycystic ovary syndrome	2.26e-05	0.000163	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTGER3—polycystic ovary syndrome	2.26e-05	0.000163	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	2.25e-05	0.000162	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	2.24e-05	0.000162	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.24e-05	0.000162	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—STAR—polycystic ovary syndrome	2.22e-05	0.00016	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—SLC2A4—polycystic ovary syndrome	2.21e-05	0.000159	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.2e-05	0.000159	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—LEP—polycystic ovary syndrome	2.19e-05	0.000158	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	2.18e-05	0.000158	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	2.18e-05	0.000157	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IRS2—polycystic ovary syndrome	2.16e-05	0.000156	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—GNAS—polycystic ovary syndrome	2.15e-05	0.000156	CbGpPWpGaD
Suramin—F2—Signaling Pathways—INHBB—polycystic ovary syndrome	2.13e-05	0.000154	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTAFR—polycystic ovary syndrome	2.12e-05	0.000153	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—LEP—polycystic ovary syndrome	2.11e-05	0.000153	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP19A1—polycystic ovary syndrome	2.07e-05	0.00015	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	2.05e-05	0.000148	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—SERPINE1—polycystic ovary syndrome	2.04e-05	0.000147	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	2e-05	0.000144	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PDE3B—polycystic ovary syndrome	1.99e-05	0.000144	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.99e-05	0.000143	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—HMMR—polycystic ovary syndrome	1.98e-05	0.000143	CbGpPWpGaD
Suramin—ARSA—Metabolism—PPARG—polycystic ovary syndrome	1.96e-05	0.000142	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.95e-05	0.000141	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—INHBB—polycystic ovary syndrome	1.95e-05	0.000141	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	1.94e-05	0.00014	CbGpPWpGaD
Suramin—ARSA—Metabolism—POMC—polycystic ovary syndrome	1.94e-05	0.00014	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	1.93e-05	0.00014	CbGpPWpGaD
Suramin—ARSA—Metabolism—INS—polycystic ovary syndrome	1.92e-05	0.000139	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—HSD3B1—polycystic ovary syndrome	1.89e-05	0.000136	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IRS1—polycystic ovary syndrome	1.89e-05	0.000136	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—POMC—polycystic ovary syndrome	1.88e-05	0.000136	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—INS—polycystic ovary syndrome	1.87e-05	0.000135	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.87e-05	0.000135	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GNAS—polycystic ovary syndrome	1.85e-05	0.000134	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PDE3B—polycystic ovary syndrome	1.82e-05	0.000131	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—POMC—polycystic ovary syndrome	1.82e-05	0.000131	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FSHR—polycystic ovary syndrome	1.81e-05	0.000131	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.81e-05	0.000131	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.81e-05	0.000131	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—INS—polycystic ovary syndrome	1.81e-05	0.00013	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—POMC—polycystic ovary syndrome	1.77e-05	0.000128	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.77e-05	0.000128	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	1.77e-05	0.000128	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—NCOR1—polycystic ovary syndrome	1.76e-05	0.000127	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GHRL—polycystic ovary syndrome	1.76e-05	0.000127	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IGF1—polycystic ovary syndrome	1.75e-05	0.000126	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AKT2—polycystic ovary syndrome	1.75e-05	0.000126	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—LHB—polycystic ovary syndrome	1.72e-05	0.000124	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.72e-05	0.000124	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.7e-05	0.000123	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—HSD3B2—polycystic ovary syndrome	1.68e-05	0.000122	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP1A1—polycystic ovary syndrome	1.67e-05	0.000121	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.66e-05	0.00012	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FSHR—polycystic ovary syndrome	1.66e-05	0.00012	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	1.66e-05	0.00012	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AKR1C1—polycystic ovary syndrome	1.63e-05	0.000118	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FST—polycystic ovary syndrome	1.61e-05	0.000117	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GHRL—polycystic ovary syndrome	1.61e-05	0.000116	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	1.6e-05	0.000116	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.59e-05	0.000115	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LHB—polycystic ovary syndrome	1.57e-05	0.000114	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MTHFR—polycystic ovary syndrome	1.56e-05	0.000113	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.56e-05	0.000112	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.54e-05	0.000111	CbGpPWpGaD
Suramin—F2—Hemostasis—IGF1—polycystic ovary syndrome	1.52e-05	0.00011	CbGpPWpGaD
Suramin—F2—Hemostasis—AKT2—polycystic ovary syndrome	1.52e-05	0.00011	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	1.51e-05	0.000109	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SULT2A1—polycystic ovary syndrome	1.5e-05	0.000108	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.49e-05	0.000108	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.49e-05	0.000107	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FST—polycystic ovary syndrome	1.48e-05	0.000107	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SCT—polycystic ovary syndrome	1.48e-05	0.000107	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.46e-05	0.000105	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.46e-05	0.000105	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—RRM2—polycystic ovary syndrome	1.45e-05	0.000105	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—LEP—polycystic ovary syndrome	1.45e-05	0.000105	CbGpPWpGaD
Suramin—F2—Hemostasis—SERPINE1—polycystic ovary syndrome	1.45e-05	0.000105	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LHB—polycystic ovary syndrome	1.44e-05	0.000104	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.41e-05	0.000102	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.41e-05	0.000102	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—YAP1—polycystic ovary syndrome	1.4e-05	0.000101	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IGF1—polycystic ovary syndrome	1.39e-05	0.000101	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—AKT2—polycystic ovary syndrome	1.39e-05	0.000101	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FGF18—polycystic ovary syndrome	1.38e-05	0.0001	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.38e-05	9.99e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RBP4—polycystic ovary syndrome	1.37e-05	9.91e-05	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.37e-05	9.87e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.36e-05	9.85e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.35e-05	9.76e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SCT—polycystic ovary syndrome	1.35e-05	9.75e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—NAMPT—polycystic ovary syndrome	1.35e-05	9.72e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.34e-05	9.67e-05	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL6—polycystic ovary syndrome	1.34e-05	9.65e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.33e-05	9.63e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP11A1—polycystic ovary syndrome	1.33e-05	9.6e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SERPINE1—polycystic ovary syndrome	1.32e-05	9.57e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.32e-05	9.53e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.29e-05	9.3e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—YAP1—polycystic ovary syndrome	1.28e-05	9.25e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.27e-05	9.14e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PPARG—polycystic ovary syndrome	1.26e-05	9.14e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GAB1—polycystic ovary syndrome	1.26e-05	9.13e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AKR1C3—polycystic ovary syndrome	1.25e-05	9.07e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.25e-05	9.06e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—POMC—polycystic ovary syndrome	1.25e-05	9.01e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—POMC—polycystic ovary syndrome	1.25e-05	9.01e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—INS—polycystic ovary syndrome	1.24e-05	8.96e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—INS—polycystic ovary syndrome	1.24e-05	8.96e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP17A1—polycystic ovary syndrome	1.24e-05	8.93e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.24e-05	8.93e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—INSR—polycystic ovary syndrome	1.21e-05	8.73e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—IGF1—polycystic ovary syndrome	1.2e-05	8.66e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.18e-05	8.53e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.17e-05	8.46e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.16e-05	8.35e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.15e-05	8.29e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.14e-05	8.24e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.13e-05	8.16e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PGR—polycystic ovary syndrome	1.12e-05	8.08e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—INSR—polycystic ovary syndrome	1.1e-05	7.98e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TH—polycystic ovary syndrome	1.07e-05	7.72e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.05e-05	7.58e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SLC2A4—polycystic ovary syndrome	1.04e-05	7.51e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PLAT—polycystic ovary syndrome	1.04e-05	7.51e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GHRL—polycystic ovary syndrome	1.04e-05	7.51e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.03e-05	7.46e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PGR—polycystic ovary syndrome	1.02e-05	7.39e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—POMC—polycystic ovary syndrome	1e-05	7.24e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—VEGFA—polycystic ovary syndrome	9.95e-06	7.19e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ATF1—polycystic ovary syndrome	9.92e-06	7.17e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP19A1—polycystic ovary syndrome	9.78e-06	7.07e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.67e-06	6.99e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.62e-06	6.96e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GHRL—polycystic ovary syndrome	9.51e-06	6.87e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PLAT—polycystic ovary syndrome	9.51e-06	6.87e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NGFR—polycystic ovary syndrome	9.15e-06	6.61e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VEGFA—polycystic ovary syndrome	9.1e-06	6.58e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—POMC—polycystic ovary syndrome	9.09e-06	6.57e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PRL—polycystic ovary syndrome	9.07e-06	6.55e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ATF1—polycystic ovary syndrome	9.07e-06	6.55e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.84e-06	6.39e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.74e-06	6.32e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GNAS—polycystic ovary syndrome	8.73e-06	6.31e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.6e-06	6.22e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NGFR—polycystic ovary syndrome	8.37e-06	6.05e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—POMC—polycystic ovary syndrome	8.32e-06	6.01e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—NCOR1—polycystic ovary syndrome	8.31e-06	6.01e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PRL—polycystic ovary syndrome	8.29e-06	5.99e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL6—polycystic ovary syndrome	8.17e-06	5.9e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.99e-06	5.78e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GNAS—polycystic ovary syndrome	7.98e-06	5.77e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL6—polycystic ovary syndrome	7.89e-06	5.7e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP1A1—polycystic ovary syndrome	7.88e-06	5.69e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.87e-06	5.69e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.6e-06	5.49e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NRG1—polycystic ovary syndrome	7.46e-06	5.39e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MTHFR—polycystic ovary syndrome	7.35e-06	5.31e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GNAS—polycystic ovary syndrome	7.3e-06	5.27e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.95e-06	5.02e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NRG1—polycystic ovary syndrome	6.82e-06	4.93e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IRS2—polycystic ovary syndrome	6.39e-06	4.62e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LEP—polycystic ovary syndrome	6.25e-06	4.52e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PPARG—polycystic ovary syndrome	5.96e-06	4.31e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—POMC—polycystic ovary syndrome	5.88e-06	4.25e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IRS2—polycystic ovary syndrome	5.84e-06	4.22e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—INS—polycystic ovary syndrome	5.84e-06	4.22e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LEP—polycystic ovary syndrome	5.72e-06	4.13e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IRS1—polycystic ovary syndrome	5.58e-06	4.03e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—POMC—polycystic ovary syndrome	5.37e-06	3.88e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—INS—polycystic ovary syndrome	5.34e-06	3.86e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF1—polycystic ovary syndrome	5.17e-06	3.73e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AKT2—polycystic ovary syndrome	5.16e-06	3.73e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IRS1—polycystic ovary syndrome	5.1e-06	3.69e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—POMC—polycystic ovary syndrome	4.91e-06	3.55e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.91e-06	3.55e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—INS—polycystic ovary syndrome	4.89e-06	3.53e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF1—polycystic ovary syndrome	4.73e-06	3.42e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AKT2—polycystic ovary syndrome	4.72e-06	3.41e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.49e-06	3.24e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6—polycystic ovary syndrome	3.95e-06	2.86e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6—polycystic ovary syndrome	3.61e-06	2.61e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.37e-06	2.44e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.09e-06	2.23e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6—polycystic ovary syndrome	2.33e-06	1.69e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6—polycystic ovary syndrome	2.13e-06	1.54e-05	CbGpPWpGaD
